SCHEMBL29659641

SCHEMBL29659641

CN(C)c1nc(NCc2ccccc2)c2ncn(C3CCCCO3)c2n1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.69
▸ RAB9A P51151 1/20 0.69
▸ SMN1; SMN2 Q16637 1/20 0.69
▸ CDK1 P06493 6/20 0.55
▸ CTSL P07711 2/20 0.52
▸ YTHDC1 Q96MU7 1/20 0.51
▸ CCNE2 O96020 3/20 0.48
▸ CCNE1 P24864 3/20 0.48
▸ CDK2 P24941 3/20 0.48
▸ FLT3 P36888 3/20 0.48
▸ CCNB2 O95067 1/20 0.48
▸ CDK4 P11802 1/20 0.48
▸ CCNB1 P14635 1/20 0.48
▸ CCND1 P24385 1/20 0.48
▸ CCNB3 Q8WWL7 1/20 0.48
▸ CDK5 Q00535 2/20 0.47
▸ ADORA3 P0DMS8 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.44
▸ CCNA2 P20248 1/20 0.43
▸ CCNA1 P78396 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547199 1.00 NPC1 (0.69) NPC1RAB9ASMN1; SMN2CDK1CTSL
SCHEMBL29659622 0.97 NPC1 (0.65) NPC1RAB9ASMN1; SMN2CDK1CTSL
SCHEMBL21954485 0.97 NPC1 (0.65) NPC1RAB9ASMN1; SMN2CDK1CTSL
SCHEMBL20547442 0.92 NPC1 (0.58) NPC1RAB9ASMN1; SMN2CDK1CTSL
SCHEMBL29659500 0.92 NPC1 (0.58) NPC1RAB9ASMN1; SMN2CDK1CTSL
SCHEMBL29659693 0.91 NPC1 (0.57) NPC1RAB9ASMN1; SMN2CDK1CTSL
SCHEMBL20547428 0.89 NPC1 (0.56) NPC1RAB9ASMN1; SMN2CDK1CTSL
SCHEMBL29659564 0.89 NPC1 (0.56) NPC1RAB9ASMN1; SMN2CDK1CTSL
SCHEMBL20547513 0.89 CCNE2 (0.61) NPC1RAB9ASMN1; SMN2CDK1CTSL
SCHEMBL29659506 0.89 CCNE2 (0.61) NPC1RAB9ASMN1; SMN2CDK1CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615535-B1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIV PALACKEHO (CZ) 2022-06-15 — — EP disclosed
Send feedback